Literature DB >> 26823043

Hepatocellular carcinoma diagnosis: Circulating microRNAs emerge as robust biomarkers.

Angélique Gougelet1, Sabine Colnot2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26823043     DOI： 10.1016/j.clinre.2015.12.010

Source DB:  PubMed          Journal:  Clin Res Hepatol Gastroenterol        ISSN： 2210-7401            Impact factor:   2.947


× No keyword cloud information.
  4 in total

1.  Exosomal microRNAs as a potential therapeutic strategy in hepatocellular carcinoma.

Authors:  Angélique Gougelet
Journal:  World J Hepatol       Date:  2018-11-27

2.  Diagnostic value of circulating miRNA-122 for hepatitis B virus and/or hepatitis C virus-associated chronic viral hepatitis.

Authors:  Xinhao Zhou; Shiqiang Fang; Mian Wang; Ali Xiong; Chao Zheng; Jiulong Wang; Changqing Yin
Journal:  Biosci Rep       Date:  2019-09-06       Impact factor: 3.840

3.  MiR-195 suppresses the metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by inhibiting YAP.

Authors:  Shuo Yu; Li Jing; Xiao-Ran Yin; Min-Cong Wang; Yi-Meng Chen; Ya Guo; Ke-Jun Nan; Li-Li Han
Journal:  Oncotarget       Date:  2017-09-15

4.  Early diagnostic evaluation of miR-122 and miR-224 as biomarkers for hepatocellular carcinoma.

Authors:  Khalda S Amr; Hanan Abd Elmawgoud Atia; Rehab Abd Elazeem Elbnhawy; Wafaa M Ezzat
Journal:  Genes Dis       Date:  2017-12-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.